Non-pharmac focus part of Accuro’s adviser push
“What we find is not many people are aware of the brand, the end users, so we’re trying to get a little bit more brand awareness out there at the moment,” said sales and marketing general manager Kelleigh Aston.
She said SmartCare+ has been welcomed by advisers since its launch in November and Accuro wanted to market its enhancements to a wider adviser audience.
“People get so much information from all of the providers, you need to remind people you have these things,” she said.
Aston said one of the key elements to the enhanced SmartCare+ cover was the addition of a non-pharmac subsidised drug benefit, something she said was included in response to market changes after OnePath and Partners Life launched non-pharmac benefits, and more importantly, from adviser feedback.
“A lot of the enhancements that we make to products are from feedback from advisers. They’re our main source of information, they are the ones in touch with clients so you get a pool effect,” she said.
“If you get lots of people saying the same things we know something needs to change.”
Aston said there was a “very loud yell” from the advice sector about non-pharmac cover, and this was one of the key additions they wanted to push to advisers to get clients to upgrade from SmartCare.
Simon Rule
Michael Lay
Ron Flood
Simon Rule
Simen Hestnæs
Steve Wright
Ron Flood
Simon Rule
Ron Flood
